Francis Medical is heating up with a 510 (k) clearance from the FDA for its water vapor ablation therapy aimed at cancers of ...
The FDA has approved the Vanquish Water Vapor Ablation System, which uses steam to destroy prostate tumors. However, the ...
Francis Medical designed its Vanquish system with needle guidance and hands-free stabilization for vapor ablation of the ...
Francis Medical has received FDA clearance for its Vanquish water vapor ablation system for the management of prostate cancer ...
Medical Device Network on MSN
FDA clears Francis Medical’s water vapour ablation treatment for prostate cancer
The Vanquish device’s clinical data demonstrated an elimination of MRI visible intermediate risk disease in 91% of patients ...
Francis Medical, Inc., a privately-held medical device company developing the breakthrough Vanquish(R) Water Vapor Ablation System for the management of prostate cancer, today announced that the U.S.
Francis Medical has obtained $80 million in venture capital funding to support the development of its water vapor ablation therapy for cancers of the prostate, kidneys and bladder. The series C round ...
MINNEAPOLIS, July 19, 2023 /PRNewswire/ -- Francis Medical, Inc., a privately held medical device company developing an innovative and proprietary water vapor ablation therapy for the treatment of ...
MINNEAPOLIS--(BUSINESS WIRE)--Francis Medical, Inc., a Minneapolis-based, privately held medical device company developing an innovative and proprietary vapor ablation therapy to treat a variety of ...
Francis Medical, Inc., a privately-held medical device company developing the breakthrough Vanquish® Water Vapor Ablation System for the management of prostate cancer, today announced that the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback